- £2.34m
- £0.39m
- £0.05m
- 14
- 23
- 33
- 10
REG - ValiRx PLC - Retail Offer
AnnouncementREG - ValiRx PLC - Agreement to License VAL401 to Ambrose Healthcare
AnnouncementREG - ValiRx PLC - Evaluation Agreement with StingRay Bio
AnnouncementREG - ValiRx PLC - Statement re Share Price Movement
AnnouncementREG - ValiRx PLC - Operational Review
AnnouncementREG - ValiRx PLC - Half-year Report
AnnouncementREG - ValiRx PLC - Collaborative Services Agreement
AnnouncementRCS - ValiRx PLC - Inaphaea BioLabs secures first external contract
AnnouncementREG - ValiRx PLC - Result of AGM
AnnouncementRCS - ValiRx PLC - Virtual AGM Access
AnnouncementRCS - ValiRx PLC - Inaphaea BioLabs Operational Update
AnnouncementREG - ValiRx PLC - Conclusion of Hokkaido Evaluation Agreement
AnnouncementREG - ValiRx PLC - Asset Purchase – Imagen Therapeutics
AnnouncementREG - ValiRx PLC - Update on proposed sub-license of VAL201
AnnouncementREG - ValiRx PLC - Expanded agreement with University of Barcelona
AnnouncementREG - ValiRx PLC - Final Results and Notice of AGM
AnnouncementREG - ValiRx PLC - Notice of Results and Investor Webinar
AnnouncementREG - ValiRx PLC - Collaborative Services Agreement
AnnouncementREG - ValiRx PLC - Quarterly Operational Update
Announcement